Building Scientific Leadership
Without a Full-Time CSO
How Fowoyo Scientific Consulting provided executive scientific leadership that accelerated product development, strengthened scientific decision-making, and helped a growing life science company scale without hiring a Chief Scientific Officer.
Growing fast, but without scientific direction
The client had secured Series A funding and was accelerating toward its first commercial product. But the founding team — experienced in operations and finance — lacked the scientific leadership to make confident decisions about formulation strategy, regulatory positioning, and evidence generation.
A full-time Chief Scientific Officer was not operationally or financially viable at this stage. The company needed someone who could function as their head of science — attending board meetings, advising the executive team, and leading technical decisions — without the overhead of a permanent hire.
Embedded scientific leadership, precisely calibrated
FSC stepped into the Fractional CSO role, integrating directly with the leadership team and operating across four defined areas of scientific stewardship.
Executive Scientific Counsel
Attended board meetings and investor briefings as the scientific voice of the company. Translated complex scientific topics into language that enabled confident executive and investor decision-making.
Product Development Oversight
Led the scientific review of formulation choices, active ingredient selection, and development timelines — establishing a structured, evidence-informed product development framework.
Regulatory Science Strategy
Defined the company's regulatory pathway and built the scientific documentation infrastructure required to meet submission standards — avoiding the costly resubmissions that affect underprepared teams.
Scientific Team Building
Evaluated internal scientific hiring needs, supported the recruitment of two senior scientists, and designed the onboarding structure that allowed the internal team to eventually operate independently.
What FSC delivered
Over fourteen months, FSC operated as a fully integrated member of the executive team — producing strategic outputs that would have required a permanent senior hire to generate.
- Product development roadmap with defined scientific milestones and evidence requirements
- Regulatory science strategy document aligned with the company's target market and product category
- Scientific due diligence report prepared for Series B investor presentations
- Formulation review and active ingredient justification across two product lines
- Scientific hiring framework and onboarding documentation for two senior scientist roles
- Board-level science briefing materials delivered across six quarterly sessions
Having FSC in the room changed the way our board and investors perceived us. We went from a team that struggled to answer scientific questions under pressure to one that could present a coherent, evidence-backed scientific narrative. That shift was entirely due to the credibility FSC brought — and built — within our organisation.
Chief Executive Officer
Life Science Startup · United States
Most growing science companies cannot afford to wait for their first CSO hire
The window between Series A and Series B is often where scientific direction matters most — and where its absence causes the greatest damage. Without senior scientific leadership, companies make formulation decisions without evidence, approach regulators without strategy, and walk into investor rooms without a coherent scientific narrative.
The Fractional CSO model gives growing companies the scientific leadership they need — at the point in their development when they need it most — without the cost, commitment, or timeline of a permanent executive search.
Ready to add scientific leadership
to your team?
FSC works with a limited number of clients at any one time. Engagements begin with a focused discovery conversation.
Schedule a Consultation View All Case Studies →